Active Ingredient History

  • Now
Pafuramidine is an experimental drug for the treatment of pneumocystis pneumonia (PCP). In 2006, pafuramidine was given orphan drug status by the US Food and Drug Administration for PCP in patients with HIV/AIDS. Preliminary clinical trials indicated that pafuramide was effective against pneumocystis pneumonia and had the potential for fewer side effects than the standard treatment with trimethoprim/sulfamethoxazole (TMP-SMX).   Wikipedia

  • SMILES: CONC(=N)c1ccc(cc1)c2oc(cc2)c3ccc(cc3)C(=N)NOC
  • Mol. Mass: 364.41
  • ALogP: 3.57
  • ChEMBL Molecules:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
2,5-bis(4-amidinophenyl)furan-bis-o-methylamidoxime | db289 | db 289 | db-289 | db289 cpd | pafuramidine | pafuramidine maleate


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue